54 completed, 10 unknown, 7 withdrawn, 3 recruiting. 76 Phase 3, 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 76 | Completed 54, Unknown 10, Withdrawn 7, Recruiting 3, Not yet recruiting 2 |
| Phase 2 | 8 | Completed 4, Not yet recruiting 1, Recruiting 1, Unknown 1, Withdrawn 1 |
Follow Allergic Rhinitis: new trials by email Literature Review of Allergic Rhinitis trials Research Report on Allergic Rhinitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis_MM09-SIT-063. EP-088_MM09, Placebo - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 250 | 2026-04-15 | 2026-10-29 |
| Parallel, Double-dummy, Superiority Study Levocetirizine/Pseudoephedrine x Zina for Allergic Rhinitis in Brazil Administration of investigation of Eurofarma drug, Administration of Comparator - Allergic Rhinitis | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2026-03-01 | 2025-12-18 | |
| Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063. EP-088_MM09, Placebo - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Recruiting | Inmunotek S.L. | 250 | 2026-02-24 | 2026-10-29 |
| A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 HDM SLIT-tablet (12 SQ-HDM), Placebo - Allergic Rhinoconjunctivitis, Allergic Rhinitis | Phase 3 | Completed | ALK-Abelló A/S | 327 | 2025-09-01 | 2026-10-05 |
| Study of Yupingfeng Powder Treating Allergic Rhinitis (AR) Chinese Herbal Medicine granules, Placebo - Allergic Rhinitis | Phase 2 / Phase 3 | Recruiting | Chinese University of Hong Kong | 140 | 2025-03-27 | 2026-07-27 |
| Efficacy and Safety of DEP114 in the Treatment of Moderate to Severe Persistent Allergic Rhinitis in Children. DEP114, Desloratadine 0.5 MG/ML - Allergic Rhinitis | Phase 3 | Not yet recruiting | EMS | 318 | 2025-02-15 | 2024-02-22 |
| Confirmatory Study on the Efficacy and Safety of the Fixed-dose Combination of Desloratadine/Betamethasone Versus Desloratadine Desloratadine / Betamethasone in fixed dose, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 70 | 2024-11-11 | 2026-07-23 |
| Efficacy and Safety of MAZ-101 in the Treatment of Persistent Allergic Rhinitis (PER) MAZ-101association, DYMISTA® - Allergic Rhinitis | Phase 3 | Unknown | EMS | 514 | 2024-09-01 | 2024-02-16 |
| Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children Desloratadine , Prednisolone, Desloratadine - Allergic Rhinitis | Phase 3 | Completed | Eurofarma Laboratorios S.A. | 262 | 2024-07-08 | 2026-10-26 |
| Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract 3,000 MM09, 9,000 MM09, Placebo sublingual - Allergic Rhinitis, Allergic Asthma | Phase 2 / Phase 3 | Not yet recruiting | Inmunotek S.L. | 90 | 2023-11-01 | 2023-10-23 |
| Study of CM310 in Subjects With Allergic Rhinitis CM310, Placebo - Allergic Rhinitis | Phase 3 | Completed | Keymed Biosciences Co.Ltd | 108 | 2023-08-10 | 2024-11-08 |
| Observation on the Efficacy and Mechanism of SLIT With Dust Mite Allergen for PAR Dust mite drops (trade name: Changdi, Zhejiang Tawu Biotechnology Co. Ltd.). - Allergic Rhinitis | Phase 2 / Phase 3 | Unknown | People's Hospital of Anshun City of Guizhou Province | 60 | 2022-12-01 | 2022-10-06 |
| Efficacy and Safety of Magnólia Nasal Gel in the Treatment of Allergic Rhinitis MAGNÓLIA NASAL GEL, MOMETASONE FUROATE - Allergic Rhinitis | Phase 3 | Withdrawn | EMS | 2022-08-01 | 2022-08-05 | |
| Effect of Sublingual Immunotherapy on Platlet factor4 Level in Children sublingual immunotherapy - Allergic Rhinitis | Phase 3 | Unknown | Zagazig University | 30 | 2021-04-12 | 2021-04-21 |
| Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Allergic Rhinitis REGN5713, REGN5714, REGN5715 - Allergic Rhinitis, Conjunctivitis | Phase 3 | Completed | Regeneron Pharmaceuticals | 353 | 2021-01-14 | 2022-10-27 |
| Adolescent Mite Allergy Safety Evaluation HDM SLIT-tablet - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Completed | ALK-Abelló A/S | 253 | 2020-09-23 | 2023-07-03 |
| Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis Azelastine hydrochloride (BAYR9258), Placebo - Allergic Rhinitis | Phase 3 | Completed | Bayer | 110 | 2020-02-03 | 2022-03-25 |
| "Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients" Phlai, Placebo oral capsule - Allergic Rhinitis | Phase 3 | Completed | Chulalongkorn University | 267 | 2020-01-31 | 2022-01-28 |
| Chlorpheniramine Maleate Nasal Spray for Chronic Rhinitis CPM, Placebo - Allergic Rhinitis, Nasal Congestion | Phase 2 / Phase 3 | Withdrawn | Larkin Community Hospital | 2019-07-30 | 2023-10-16 | |
| Efficacy and Safety of the Mometasone Nasal Gel in the Treatment of Persistent Allergic Rhinitis EMS Mometasone gel, Mometasone spray nasal - Allergic Rhinitis | Phase 3 | Withdrawn | EMS | 2019-05-01 | 2020-11-04 |
Showing 20 of 76. Sign in to see all of them.
Rhinitis, Allergic (76) · Hypersensitivity (11) · Rhinitis, Allergic, Seasonal (11) · Rhinitis, Allergic, Perennial (7) · Asthma (4) · Rhinitis (4) · Conjunctivitis, Allergic (3) · Chronic Urticaria (2) · Nasal Obstruction (2) · Bronchiolitis (1) · Conjunctivitis (1) · Constipation (1) · Croup (1) · Dermatitis, Atopic (1) · Dust Mite Allergy (1)
Hypersensitivity, Immediate (76) · Immune System Diseases (76) · Nose Diseases (76) · Otorhinolaryngologic Diseases (76) · Respiratory Hypersensitivity (76) · Respiratory Tract Diseases (76) · Rhinitis (72) · Hypersensitivity (65) · Bronchial Diseases (5) · Infections (5) · Lung Diseases (5) · Lung Diseases, Obstructive (5) · Respiratory Tract Infections (5) · Conjunctival Diseases (4) · Eye Diseases (4)
desloratadine (9) · Mometasone Furoate (7) · levocetirizine (4) · Beclomethasone (3) · Betamethasone (3) · Prednisolone (3) · Sublingual Immunotherapy (3) · ciclesonide (3) · Allergens (2) · Broncho-Vaxom (2) · Cetirizine (2) · Fluticasone (2) · Loratadine (2) · azelastine (2) · bu-zhong-yi-qi-tang (2)
Organon and Co (9) · EMS (7) · ALK-Abelló A/S (5) · Roxall Medizin (5) · AstraZeneca (3) · Chang Gung Memorial Hospital (3) · Eurofarma Laboratorios S.A. (3) · Inmunotek S.L. (3) · GlaxoSmithKline (2) · Medical University of Lublin (2) · Stallergenes Greer (2) · Teva Branded Pharmaceutical Products R&D, Inc. (2) · UCB Pharma (2) · University of Chicago (2) · Ahn-Gook Pharmaceuticals Co.,Ltd (1)
United States (16) · China (8) · Germany (8) · Brazil (5) · Spain (4) · Canada (3) · Poland (3) · Sweden (3) · Taiwan (3) · Czechia (2) · Denmark (2) · Finland (2) · Italy (2) · Portugal (2) · Slovakia (2)
Sien-hung Yang, Ph.D. (2) · Andreas Fisher (1) · Andreas Horn, MD (1) · Chae-Seo Rhee, M.D. (1) · Chang-Hoon Kim, M.D. (1) · Chia-yu Ou, MD (1) · Chuanjian Lu, Doctor (1) · Dae-Woo Kim, M.D. (1) · DucTung Nguyen, Dr. (1)
PMID 20819318, PMID 21439168, PMID 12668793, PMID 14674933, PMID 15313870, PMID 15461603, PMID 15516669, PMID 15750716, PMID 15898976, PMID 16930249, PMID 18331513, PMID 19925886, PMID 19968632, PMID 20545698, PMID 20559006, PMID 20816182, PMID 21121983, PMID 21122901, PMID 21783242, PMID 21888757, PMID 22131999, PMID 22224763, PMID 22361496, PMID 22370530, PMID 22627366, PMID 22925325, PMID 22994348, PMID 23348417, PMID 23676577, PMID 23791985, PMID 24388010, PMID 24517417, PMID 24631153, PMID 24679069, PMID 24852424, PMID 25171868, PMID 25624132, PMID 25644617, PMID 26115578, PMID 26141263, PMID 26250771, PMID 26300945, PMID 26874355, PMID 26922931, PMID 26932169, PMID 26949057, PMID 27329923, PMID 28602936, PMID 28785597, PMID 28917723
2009 (1), 2015 (1), 2018 (1), 2025 (1)